Mike Schopperle of CureMeta joined us at Americas Antibody Congress 2016 to discuss ‘ADCs targeting embryoninc pluripotent stem cell markers’
Download this presentation to understand more about:
- Main focus in cancer drug development: oncogenes
- Common embryonic element present in all cancers
- CureMeta’s product engine to generate high specificity and high affinity antibodies to embryonic targets.
and much more !
Get your copy here !
If you’re interested in learning more about ADCs and their targets, join us at Americas Antibody Congress 2017 , held May 23-24 in San Diego, CA . This event is co-located with World Biosimilar Congress USA and Cell Culture World Congress USA .